| Product NDC: | 24090-470 |
| Proprietary Name: | Inderal |
| Non Proprietary Name: | propranolol hydrochloride |
| Active Ingredient(s): | 60 mg/1 & nbsp; propranolol hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24090-470 |
| Labeler Name: | Akrimax Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018553 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19830419 |
| Package NDC: | 24090-470-88 |
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24090-470-88) |
| NDC Code | 24090-470-88 |
| Proprietary Name | Inderal |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24090-470-88) |
| Product NDC | 24090-470 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | propranolol hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19830419 |
| Marketing Category Name | NDA |
| Labeler Name | Akrimax Pharmaceuticals, LLC |
| Substance Name | PROPRANOLOL HYDROCHLORIDE |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |